Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Mary Cabiddu"'
Autor:
Fausto Petrelli, Gianluca Tomasello, Maria Chiara Parati, Antonio Ghidini, Michele Ghidini, Karen Borgonovo, Mary Cabiddu, Mara Ghilardi, Roberto Reduzzi, Donatella Gambini, Alberto Zaniboni, Giovanni Faustinelli, Ornella Garrone
Publikováno v:
Medicina, Vol 60, Iss 2, p 341 (2024)
Background and Objectives: Currently, the standard treatment for non-metastatic triple-negative breast cancer (TNBC) consists of a systemic neoadjuvant (or perioperative) anthracycline plus taxane-based chemotherapy, delivered either sequentially or
Externí odkaz:
https://doaj.org/article/447ce7c1855a4d538871ad2af9d3bfd5
Autor:
Fausto Petrelli, Simone Oldani, Karen Borgonovo, Mary Cabiddu, Giuseppina Dognini, Mara Ghilardi, Maria Chiara Parati, Daniela Petro’, Lorenzo Dottorini, Carmen Rea, Veronica Lonati, Andrea Luciani, Antonio Ghidini
Publikováno v:
Antioxidants, Vol 12, Iss 2, p 247 (2023)
Background: The immune system (innate and adaptive) is influenced by vitamin D3, which affects gene expression and inflammatory pathways. An umbrella review was conducted to evaluate the power and accuracy of data connecting vitamin D3 to the outcome
Externí odkaz:
https://doaj.org/article/11816e08db204da39f8e20477cc5da87
Autor:
Fausto Petrelli, Chiara Lazzari, Raffaele Ardito, Karen Borgonovo, Alessandra Bulotta, Barbara Conti, Mary Cabiddu, Jody Filippo Capitanio, Matteo Brighenti, Mara Ghilardi, Luca Gianni, Sandro Barni, Vanesa Gregorc
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0201425 (2018)
BACKGROUND:Patients with anaplastic lymphoma kinase rearranged (ALK+) non-small cell lung cancer (NSCLC) have a higher risk of developing brain metastases (BMs) than patients with other NSCLC sub-types. ALK inhibitors have activity in BMs due to ALK+
Externí odkaz:
https://doaj.org/article/987027085c5548c5a9b42f67286c86e2
Autor:
Fausto Petrelli, Alberto Zaniboni, Andrea Coinu, Mary Cabiddu, Mara Ghilardi, Giovanni Sgroi, Sandro Barni
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83022 (2013)
BACKGROUND: Cisplatin-based chemotherapy is frequently used to treat advanced gastric cancer (GC). Although it leads to increased overall survival (OS) when added to single agents or chemotherapy doublets, toxicity is also generally increased. The pu
Externí odkaz:
https://doaj.org/article/70377bfb4a26494f9c91d90ca6974cd5
Autor:
Maria Chiara Parati, Rebecca Pedersini, Gianluca Perego, Roberto Reduzzi, Tommaso Savio, Mary Cabiddu, Karen Borgonovo, Mara Ghilardi, Andrea Luciani, Fausto Petrelli
Publikováno v:
Breast Cancer: Targets and Therapy. 14:101-111
Among pre- and postmenopausal women with hormone receptor-positive (HR+) breast cancer (BC), combinations of an aromatase inhibitor (AI) or fulvestrant with a CDK 4/6 inhibitor (palbociclib, ribociclib, or abemaciclib) have demonstrated improved prog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66ccd61a517f41852f5a71418450791a
https://doi.org/10.2147/bctt.s341857
https://doi.org/10.2147/bctt.s341857
Autor:
Sara Monteverdi, Antonio Ghidini, Sandro Barni, Rebecca Pedersini, Karen Borgonovo, Mary Cabiddu, Lucia Vassalli, Maria Chiara Parati, Mara Ghilardi, Edda Simoncini, Vito Amoroso, Mara Ardine, Antonella Turla, Alberto Dalla Volta, Alfredo Berruti, Fausto Petrelli, Pierluigi di Mauro
Publikováno v:
Journal of Geriatric Oncology. 11:976-981
Purpose Eribulin mesylate (EM) is a non-taxane microtubule inhibitor approved for use in patients with metastatic breast cancer. With this pooled analysis of retrospective studies, we evaluated the efficacy and toxicity profile of EM in older patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73d6877afb887c6c82f5d11338d49b6e
https://doi.org/10.1016/j.jgo.2020.03.021
https://doi.org/10.1016/j.jgo.2020.03.021
Autor:
Nicola Fusco, Antonio Ghidini, Gianluca Tomasello, Francesco Grossi, Fausto Petrelli, Andrea Botticelli, Michele Ghidini, Giulia Grizzi, Tommaso Savio, Mary Cabiddu
Publikováno v:
Cancer Management and Research, Vol Volume 12, Pp 675-686 (2020)
Cancer Management and Research
Cancer Management and Research
Giulia Grizzi,1 Michele Ghidini,2 Andrea Botticelli,3,4 Gianluca Tomasello,5 Antonio Ghidini,6 Francesco Grossi,2 Nicola Fusco,7,8 Mary Cabiddu,9 Tommaso Savio,10 Fausto Petrelli9 1Oncology Unit, Oncology Department, ASST of Cremona, Cremona, Italy;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1827d1c140e47f6f8a458a2962ff8f54
https://doi.org/10.2147/cmar.s202965
https://doi.org/10.2147/cmar.s202965
Autor:
Fausto Petrelli, Andrea Luciani, Karen Borgonovo, Mara Ghilardi, Maria Chiara Parati, Daniela Petrò, Veronica Lonati, Angelo Pesenti, Mary Cabiddu
Publikováno v:
Journal of medical virology. 94(6)
We analyzed published studies on the efficacy and safety of the third dose of the COVID-19 vaccine in various general population settings. We conducted systematic searches of PubMed and EMBASE for series published in the English language through Nove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28a85f23efc460e9f426696c5cb622ae
https://pubmed.ncbi.nlm.nih.gov/35521674
https://pubmed.ncbi.nlm.nih.gov/35521674
Autor:
Fausto Petrelli, Mary Cabiddu, Andrea Luciani, Mara Ghilardi, Karen Borgonovo, Maria Chiara Parati
Publikováno v:
European Journal of Cancer. 147:151-153
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c9e528957ed83b853bc671fe7e10807
https://doi.org/10.1016/j.ejca.2021.01.030
https://doi.org/10.1016/j.ejca.2021.01.030
Autor:
Fausto Petrelli, Mary Cabiddu, Karen Borgonovo, Maria Chiara Parati, Mara Ghilardi, Gianluca Perego, Andrea Luciani
Publikováno v:
Thrombosis research. 210
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6f9b8d61292d06c9a61b6b86d1b1381
https://pubmed.ncbi.nlm.nih.gov/35007938
https://pubmed.ncbi.nlm.nih.gov/35007938